BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25041609)

  • 41. Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.
    Montserrat E; Viñolas N; Reverter JC; Rozman C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):359-61. PubMed ID: 3222145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.
    Fabris S; Mosca L; Cutrona G; Lionetti M; Agnelli L; Ciceri G; Barbieri M; Maura F; Matis S; Colombo M; Gentile M; Recchia AG; Anna Pesce E; Di Raimondo F; Musolino C; Gobbi M; Di Renzo N; Mauro FR; Brugiatelli M; Ilariucci F; Lipari MG; Angrilli F; Consoli U; Fragasso A; Molica S; Festini G; Vincelli I; Cortelezzi A; Federico M; Morabito F; Ferrarini M; Neri A
    Am J Hematol; 2013 Jan; 88(1):24-31. PubMed ID: 23044996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
    Chi DS; Palayekar MJ; Sonoda Y; Abu-Rustum NR; Awtrey CS; Huh J; Eisenhauer EL; Barakat RR; Kattan MW
    Gynecol Oncol; 2008 Jan; 108(1):191-4. PubMed ID: 17950784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03).
    Lee HJ; Han S; Kim YS; Nam JH; Kim HJ; Kim JW; Park W; Kim BG; Kim JH; Cha SD; Kim J; Lee KH; Yoon MS; Kim SM; Kim JY; Yoon WS; Lee NW; Choi JH; Park SY; Kim JY
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):659-64. PubMed ID: 24138914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease.
    Lin TT; Norris K; Heppel NH; Pratt G; Allan JM; Allsup DJ; Bailey J; Cawkwell L; Hills R; Grimstead JW; Jones RE; Britt-Compton B; Fegan C; Baird DM; Pepper C
    Br J Haematol; 2014 Oct; 167(2):214-23. PubMed ID: 24990087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single unit lymphoma experience: outcome in a Cape Town academic centre.
    Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
    Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
    Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Cavazzini F; Squillace R; Mirabelli R; Digiesi G
    Eur J Haematol; 2003 Jun; 70(6):373-8. PubMed ID: 12756019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia.
    Nenova I; Mateva N; Ananoshtev N; Grudeva-Popova J
    Hematology; 2005 Feb; 10(1):47-51. PubMed ID: 16019445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [B-chronic lymphocytic leukemia: epidemiological study and comparison of MDACC and GIMENA pronostic indexes].
    González Rodríguez AP; González García E; Fernández Alvarez C; González Huerta AJ; González Rodríguez S
    Med Clin (Barc); 2009 Jul; 133(5):161-6. PubMed ID: 19539961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma.
    Liu Q; Feng L; Xue H; Su W; Li G
    Medicine (Baltimore); 2020 Mar; 99(10):e19199. PubMed ID: 32150058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome.
    Callea V; Morabito F; Oliva BM; Stelitano C; Levato D; Dattilo A; Gangemi F; Iorfida A; Iacopino P; Nobile F; Molica S; Brugiatelli M
    Br J Haematol; 1999 Nov; 107(2):347-52. PubMed ID: 10583223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The establishment and evaluation of a new model for the prediction of Children B-ALL based on TARGET: A SQUIRE-compliant study.
    Gao X; Liu W
    Medicine (Baltimore); 2020 May; 99(19):e20115. PubMed ID: 32384487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia.
    Gao R; Du K; Liang J; Xia Y; Wu J; Li Y; Pan B; Wang L; Li J; Xu W
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors in stage AO B-cell chronic lymphocytic leukaemia.
    Oscier DG; Stevens J; Hamblin TJ; Pickering RM; Fitchett M
    Br J Haematol; 1990 Nov; 76(3):348-51. PubMed ID: 2261344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression.
    Giles FJ; Bekele BN; O'Brien S; Cortes JE; Verstovsek S; Balerdi M; Yared M; Zhou X; Kantarjian HM; Keating MJ; Thall P; Albitar M
    Br J Haematol; 2003 May; 121(4):578-85. PubMed ID: 12752098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
    González-Gascón-Y-Marín I; Muñoz-Novas C; Figueroa I; Hernández-Sánchez M; Rodríguez-Vicente AE; Quijada-Álamo M; Pérez-Carretero C; Moreno C; Collado R; Espinet B; Puiggros A; Heras NL; Bosch F; Hernández JÁ;
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):548-555.e4. PubMed ID: 32389671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.